Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18 recalls · Class II, newest first

Class II · Moderate risk

Rocuronium Bromide 50 MG/5ML INJ.

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 61786-0222-57 D-0517-2016
Class II · Moderate risk

Novolin 70/30

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 52125-0414-01 D-0516-2016
Class II · Moderate risk

Lorazepam 2 mg/mL Inj.

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 61786-0316-01 D-0515-2016
Class II · Moderate risk

Ascorbic Acid 500 MG/ML Inj.

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 61786-0431-16 D-0514-2016
Class II · Moderate risk

Vitamin B-Complex 100

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 52125-0873-02 D-0513-2016
Class II · Moderate risk

Bicillin L-A 600000 Units/mL Inj.

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 61786-0253-03 D-0512-2016
Class II · Moderate risk

Humulin 70/30

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 52125-0415-08 D-0511-2016
Class II · Moderate risk

Kindest Kare Antimicrobial Foaming Handwash

Labeling: Not Elsewhere Classified; Incorrect/Undeclared Excipients: Outdated previous version of label applied to products that incorrectly states one inactive ingredient.

Terminated Labeling / mix-up Steris Corp NDC 0519-1452-13 D-0518-2016
Class II · Moderate risk

WellPatch¿ Capsaicin Pain Relief Patch

Labeling: Incorrect Instructions; The word not is missing from the following sentences "do bandage tightly or cover with any type of wrap except clothing and "do use with a heating pad or with other heat sources in the Drug Facts panel "Warning" section

Terminated Labeling / mix-up The Mentholatum Co. NDC 10742-8126-2 D-0018-2016
Class II · Moderate risk

SUCRETS Sore Throat & Cough Vapor Cherry lozenges

Labeling: Label Mix-Up: An incorrect book label for Sucrets Sore Throat, Cough & Dry Mouth Honey Lemon lozenges was applied to the underside of the Sucrets Sore Throat & Cough Vapor Cherry lozenges tin.

Terminated Labeling / mix-up Medtech Products, Inc. D-1113-2015
Class II · Moderate risk

MD-Gastroview

Labeling: incorrect or missing lot number and/or expiration date

Terminated Labeling / mix-up Mallinckrodt, Inc. NDC 0019-4816-04 D-1132-2015
Class II · Moderate risk

Kabiven

Labeling: Label Error on Declared Strength: Labeled 3.1% Amino Acids but contains 3.3% Amino Acids

Terminated Labeling / mix-up Fresenius Kabi USA, LLC D-1114-2015
Class II · Moderate risk

Mucinex Fast Max DM Max

Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.

Terminated Labeling / mix-up Reckitt Benckiser LLC NDC 63824-019-66 D-1369-2015
Class II · Moderate risk

C-Topical 4% CII

Labeling: Label mix-up; bottles were incorrectly labeled as 10 mL instead of correctly labeled as 4 mL

Terminated Labeling / mix-up Cody Laboratories, Inc. NDC 0527-1728-74 D-0992-2015
Class II · Moderate risk

Glycopyrrolate injection

Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the "y" and "3" making the actual "Use By 3/2015" date appear to read "Use By8/2015".

Terminated Labeling / mix-up SCA Pharmaceuticals D-0339-2015

Recalls by year